We are live on ! Find out more
MAP

Moody Aldrich Partners Portfolio holdings

AUM $557M
1-Year Est. Return 122.79%
This Fund
S&P 500
This Quarter Est. Return
+16.87%
1 Year Est. Return
+122.79%
3 Year Est. Return
+335.86%
5 Year Est. Return
+437.05%
10 Year Est. Return
+2,951.39%
AUM
$588M
AUM Growth
+$32M
Cap. Flow
-$19.1M
Cap. Flow %
-3.26%
Top 10 Hldgs %
17.49%
Holding
244
New
49
Increased
43
Reduced
112
Closed
29

Top Buys

Rank Stock Value
1
MOD icon
Modine Manufacturing
MOD
+$5.42M
2
HALO icon
Halozyme
HALO
+$4.65M
3
FN icon
Fabrinet
FN
+$4.41M
4
APPF icon
AppFolio
APPF
+$4.23M
5
ASO icon
Academy Sports + Outdoors
ASO
+$3.77M

Sector Composition

Rank Sector Weight
1 Healthcare 17.82%
2 Industrials 15.14%
3 Consumer Discretionary 13.61%
4 Financials 13.51%
5 Technology 13.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTRA
101
DELISTED
Coterra Energy
CTRA
$1.85M 0.32%
+66,529
New +$1.71M
AFL icon
102
Aflac
AFL
$62.6B
$1.85M 0.31%
+21,509
New +$1.76M
SYF icon
103
Synchrony
SYF
$25.6B
$1.83M 0.31%
42,470
-13,244
-24% -$528K
DFS
104
DELISTED
Discover Financial Services
DFS
$1.83M 0.31%
13,923
ABBV icon
105
AbbVie
ABBV
$435B
$1.79M 0.31%
9,847
+321
+3% +$55.3K
ALKS icon
106
Alkermes
ALKS
$8.25B
$1.79M 0.3%
66,208
+13,638
+26% +$387K
BRZE icon
107
Braze
BRZE
$2.99B
$1.79M 0.3%
+40,369
New +$2.18M
REGN icon
108
Regeneron Pharmaceuticals
REGN
$80.8B
$1.79M 0.3%
1,856
-137
-7% -$130K
BBY icon
109
Best Buy
BBY
$17.3B
$1.69M 0.29%
20,661
BHVN icon
110
Biohaven
BHVN
$2.21B
$1.67M 0.28%
+30,547
New +$1.51M
SIG icon
111
Signet Jewelers
SIG
$3.76B
$1.6M 0.27%
15,994
-8,403
-34% -$840K
POWI icon
112
Power Integrations
POWI
$3.61B
$1.54M 0.26%
21,571
-5,996
-22% -$448K
ARWR icon
113
Arrowhead Research
ARWR
$12.4B
$1.52M 0.26%
53,039
-1,055
-2% -$33.8K
ACLX
114
DELISTED
Arcellx
ACLX
$1.43M 0.24%
+20,560
New +$1.3M
MDGL icon
115
Madrigal Pharmaceuticals
MDGL
$11.8B
$1.37M 0.23%
5,124
-4,099
-44% -$966K
MSFT icon
116
Microsoft
MSFT
$3.71T
$1.35M 0.23%
3,217
-1,158
-26% -$469K
NVDA icon
117
NVIDIA
NVDA
$5.42T
$1.18M 0.2%
13,060
-2,510
-16% -$182K
SLAB icon
118
Silicon Laboratories
SLAB
$7.23B
$1.16M 0.2%
8,098
-9,883
-55% -$1.31M
VRTX icon
119
Vertex Pharmaceuticals
VRTX
$126B
$1.16M 0.2%
2,764
+423
+18% +$179K
LLY icon
120
Eli Lilly
LLY
$1.06T
$1.03M 0.17%
1,321
-442
-25% -$315K
AMGN icon
121
Amgen
AMGN
$222B
$910K 0.15%
3,202
-1
-0% -$293
SWTX
122
DELISTED
SpringWorks Therapeutics
SWTX
$890K 0.15%
+18,080
New +$836K
KNSL icon
123
Kinsale Capital Group
KNSL
$8.51B
$825K 0.14%
1,573
+269
+21% +$122K
UTHR icon
124
United Therapeutics
UTHR
$23.1B
$798K 0.14%
3,475
+1,451
+72% +$327K
MRK icon
125
Merck
MRK
$318B
$760K 0.13%
5,760
-1,929
-25% -$238K

Similar funds

Moody Aldrich Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Moody Aldrich Partners held 244 positions worth $588M, up 5.7% from $556M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Moody Aldrich Partners withdrew a net $19.1M in Q1 2024, closing 29 positions and reducing 112 holdings. Its most notable exit was The Bancorp, an estimated $7.18M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Moody Aldrich Partners opened a new position in Modine Manufacturing worth $6.67M.

  • Moody Aldrich Partners's largest Q1 2024 buy was Modine Manufacturing: 70,074 shares worth $6.67M.
  • Moody Aldrich Partners added most to AppFolio in Q1 2024, an estimated $4.23M increase.
  • Moody Aldrich Partners's biggest Q1 2024 reduction was Super Micro Computer, cutting an estimated $6.14M.
  • Moody Aldrich Partners fully exited The Bancorp in Q1 2024, selling an estimated $7.18M.
  • Moody Aldrich Partners's ten largest holdings make up 17% of its $588M portfolio in Q1 2024.
  • Moody Aldrich Partners opened 49 new positions and closed 29 in Q1 2024.
  • Moody Aldrich Partners's portfolio value rose 5.7% quarter-over-quarter to $588M.

Based on Moody Aldrich Partners's 13F filing for Q1 2024, filed 30 Apr 2024.